STAT+: Pharma tries to tamp down broad China restrictions
Summary
AI-focused VC firm raises $800M, Merck's new cholesterol pill, and more biotech news from The Readout
Why It Matters
This Biotech development strengthens the region's biomanufacturing and life-sciences base. For China, it is a signal worth tracking: it shapes who supplies, who scales, and who sets the standard over the next five years.
Key Facts
- SectorBiotech
- MarketChina
- ImpactMedium (56/100)
- SignalFunding